CODX
Co-Diagnostics, Inc.
3.08
2 x 2.19
2 x 3.49
bid
ask
-
0.02
0.65%
2 @ 08:52 AM
3.03 -0.05 (1.62%)
Ytd-39.25%
1y-63.07%
2.71
day range
4.57
1.26
52 week range
46.50
Open3.30Prev Close3.10Low2.71High4.57Mkt Cap11.26M
Vol6.76MAvg Vol5.86MEPS-32.26P/EN/AForward P/E-0.62
Beta-0.85Short Ratio1.77Inst. Own13.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg3.49200-d Avg6.081yr Est1.50

CODX News

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
prnewswire.com
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of

More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 2

EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
benzinga.com
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform

Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plan

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
prnewswire.com
Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in hono

benzinga.com
Co-Diagnostics Announces Delegation Visit From CoMira Diagnostics At Co. Headquarters In Salt Lake C

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnosti

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
Co-Diagnostics Enters Into Exclusive Distribution Agreement With Partner In Mexico For Co-Dx PCR Poi

Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro® and expanding menu

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
prnewswire.com
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Di

Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro ® and expanding men

benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

benzinga.com
Co-Diagnostics Advances Dual Ebola PCR Testing Program To Enhance Outbreak Detection And Surveillanc

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regio

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
prnewswire.com
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform C

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regio

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Is Co-Diagnostics National Security's Next Diagnostic Pick?
marketbeat.com
Is Co-Diagnostics National Security's Next Diagnostic Pick?

A structural shift is underway in the biodefense landscape. The declaration of a Public Health Emerg

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
Co-Diagnostics Advances Its PCR Assay Development Strategy For The Bundibugyo Virus, Aided By Cosara

 Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnost

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
prnewswire.com
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Joint development strategy has been developed to address international deployment requirements if cu

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

What's Going On With Co-Diagnostics Stock Wednesday?
benzinga.com
What's Going On With Co-Diagnostics Stock Wednesday?

Co-Diagnostics shares jump 28% following a $3.0M private placement and key progress on its Bundibugy

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
prnewswire.com
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "C

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
prnewswire.com
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Recent pathogens illustrate need for improved situational awareness capabilities, such as those prov

benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebo

https://www.cdc.gov/ebola/situation-summary/index.html

Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript
seekingalpha.com
Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript

Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript

Co-Diagnostics Q1 2026 Earnings Call Transcript
benzinga.com
Co-Diagnostics Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Co-Diagnostics Reports First Quarter 2026 Financial Results
prnewswire.com
Co-Diagnostics Reports First Quarter 2026 Financial Results

Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion Executi

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
Co-Diagnostics Announces That Its JV CoMira Diagnostics Finalized A Lease Agreement For Its Planned

he lease execution represents a key milestone as CoMira advances domestic manufacturing capabilities

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
prnewswire.com
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Ar

Lease execution highlights transition from approval to development and advances localized manufactur

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
prnewswire.com
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

SALT LAKE CITY, April 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
prnewswire.com
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Departm

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
prnewswire.com
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Company to engage with global customers and distributors while expanding international commercial re

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
prnewswire.com
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Trade mission itinerary of business, government, and industry briefings across Switzerland and Germa

benzinga.com
Co-Diagnostics JV CoMira Secures Industrial Land Allocation In Sudair Industrial City In Riyadh Regi

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufactu

Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript
seekingalpha.com
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript

Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY

Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent d

Co-Diagnostics Reports Full Year 2025 Financial Results
prnewswire.com
Co-Diagnostics Reports Full Year 2025 Financial Results

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures Progressing Cli

Earnings Scheduled For March 31, 2026
benzinga.com
Earnings Scheduled For March 31, 2026

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
prnewswire.com
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies F

The near-term commencement of clinical studies is expected to align with recent WHO tuberculosis rec

EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
benzinga.com
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

These materials are necessary to begin clinical performance studies of the TB test on the PCR platfo

EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
benzinga.com
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

Co-Diagnostics ships PCR Pro and TB test kits to India, advancing clinical studies as the WHO backs